Vice President, Federal Government Affairs & Policy
BioMarin Pharmaceutical Inc.
August 31, 2026
Remote friendly (Washington, DC)
United States
$277,400 - $385,000 USD yearly
Corporate Functions
Position Summary
- Hybrid role: minimum 2 days/week onsite in Washington, DC.
- Develop and execute BioMarin’s federal advocacy strategy to advance U.S. federal policy priorities supporting innovation, patient access, preservation of development incentives, and growth in the rare disease market.
- Advise executive leadership on federal policy developments; lead engagement with Congress to shape legislation affecting the company’s pipeline/commercial portfolio and the broader rare disease ecosystem.
Key Responsibilities
- Develop/own federal government affairs strategy aligned with corporate objectives; drive favorable policy actions.
- Influence federal legislation and Executive Branch policy/regulation on: drug pricing/coverage/reimbursement and patient access (Medicaid/Medicare), FDA regulatory frameworks, tax/trade policy affecting R&D and innovation, orphan drug policy and rare disease legislation, and emerging healthcare reforms.
- Oversee policy materials (briefings, white papers, comment letters) and marshal evidence/data.
- Build relationships with Members of Congress/staff, committees, federal agencies, White House/Executive Branch officials.
- Lead engagement plans for priority legislation and executive actions.
- Build/lead high-performing team; ensure oral/written advocacy and communications.
- Drive executive participation in hearings/briefings/policy forums; prepare leadership for meetings/testimony.
- Represent in select industry associations; lead coalition/alliance strategy with patient advocacy groups.
- Partner cross-functionally (Market Access, Legal/Compliance, Medical/Regulatory Affairs, Communications/Patient Advocacy, Investor Relations, Finance).
- Ensure policy messaging consistency; oversee BioMarinPAC strategy and compliant management.
- Oversee political/lobbying reporting/disclosure; maintain governance/ethical standards; manage external lobbying firms/consultants.
Education
- Bachelor’s degree required; JD/MPP/MPH/MBA highly preferred.
Experience
- 15+ years in federal government affairs/public policy/healthcare advocacy (strategy development/execution).
- Experience in biotechnology/pharmaceutical/healthcare policy; working with senior Congress/federal officials and c-suite executives; influencing complex healthcare legislation; managing external lobbying firms/coalitions.
Core Competencies
- U.S. federal legislative/regulatory expertise; healthcare policy/reimbursement knowledge; orphan drug policy understanding; strategic risk/opportunity assessment; executive-level influence/communications; bipartisan relationship-building; integrity; crisis management.
Measures of Success
- Advance policy priorities; protect company interests; strong policymaker relationships; anticipate/mitigate policy risks; align strategy with corporate objectives; compliance/governance excellence.
- Hybrid role: minimum 2 days/week onsite in Washington, DC.
- Develop and execute BioMarin’s federal advocacy strategy to advance U.S. federal policy priorities supporting innovation, patient access, preservation of development incentives, and growth in the rare disease market.
- Advise executive leadership on federal policy developments; lead engagement with Congress to shape legislation affecting the company’s pipeline/commercial portfolio and the broader rare disease ecosystem.
Key Responsibilities
- Develop/own federal government affairs strategy aligned with corporate objectives; drive favorable policy actions.
- Influence federal legislation and Executive Branch policy/regulation on: drug pricing/coverage/reimbursement and patient access (Medicaid/Medicare), FDA regulatory frameworks, tax/trade policy affecting R&D and innovation, orphan drug policy and rare disease legislation, and emerging healthcare reforms.
- Oversee policy materials (briefings, white papers, comment letters) and marshal evidence/data.
- Build relationships with Members of Congress/staff, committees, federal agencies, White House/Executive Branch officials.
- Lead engagement plans for priority legislation and executive actions.
- Build/lead high-performing team; ensure oral/written advocacy and communications.
- Drive executive participation in hearings/briefings/policy forums; prepare leadership for meetings/testimony.
- Represent in select industry associations; lead coalition/alliance strategy with patient advocacy groups.
- Partner cross-functionally (Market Access, Legal/Compliance, Medical/Regulatory Affairs, Communications/Patient Advocacy, Investor Relations, Finance).
- Ensure policy messaging consistency; oversee BioMarinPAC strategy and compliant management.
- Oversee political/lobbying reporting/disclosure; maintain governance/ethical standards; manage external lobbying firms/consultants.
Education
- Bachelor’s degree required; JD/MPP/MPH/MBA highly preferred.
Experience
- 15+ years in federal government affairs/public policy/healthcare advocacy (strategy development/execution).
- Experience in biotechnology/pharmaceutical/healthcare policy; working with senior Congress/federal officials and c-suite executives; influencing complex healthcare legislation; managing external lobbying firms/coalitions.
Core Competencies
- U.S. federal legislative/regulatory expertise; healthcare policy/reimbursement knowledge; orphan drug policy understanding; strategic risk/opportunity assessment; executive-level influence/communications; bipartisan relationship-building; integrity; crisis management.
Measures of Success
- Advance policy priorities; protect company interests; strong policymaker relationships; anticipate/mitigate policy risks; align strategy with corporate objectives; compliance/governance excellence.